A study published on PubMed examines the clinical profile of uveitis in leprosy patients in Egypt, providing insights into the ocular complications associated with the disease. This research contributes to the understanding of leprosy-related conditions and their management.

Regeneron has discontinued a clinical study for an antibody targeting uveitis due to an unfavorable risk/benefit profile. This decision follows recent Phase 3 failures of itepekimab and a combination regimen for melanoma.

Regeneron has discontinued a clinical study for an antibody targeting uveitis due to safety concerns. This decision follows recent Phase 3 failures of itepekimab and a combination regimen for melanoma.

A recent study explores the characteristics of uveitis associated with juvenile idiopathic arthritis (JIA) during the transition age. The findings may provide insights into managing this condition in young patients.

A case report highlights the occurrence of herpes simplex virus type 1 uveitis in the fellow eye following intravitreal administration of bevacizumab. This finding may prompt further investigation into the safety profile of bevacizumab in patients with a history of herpes virus infections.